<VariationArchive VariationID="530654" VariationName="NC_000002.12:g.(?_165090130)_(166228992_?)del" VariationType="Deletion" Accession="VCV000530654" Version="5" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2018-05-28" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="516160" VariationID="530654">
      <GeneList>
        <Gene Symbol="SCN9A" FullName="sodium voltage-gated channel alpha subunit 9" GeneID="6335" HGNC_ID="HGNC:10597" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="166195185" stop="166375987" display_start="166195185" display_stop="166375987" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="167051694" stop="167232496" display_start="167051694" display_stop="167232496" Strand="-" />
          </Location>
          <OMIM>603415</OMIM>
        </Gene>
        <Gene Symbol="TTC21B" FullName="tetratricopeptide repeat domain 21B" GeneID="79809" HGNC_ID="HGNC:25660" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165873362" stop="165953776" display_start="165873362" display_stop="165953776" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166729871" stop="166810347" display_start="166729871" display_stop="166810347" Strand="-" />
          </Location>
          <OMIM>612014</OMIM>
        </Gene>
        <Gene Symbol="TTC21B-AS1" FullName="TTC21B antisense RNA 1" GeneID="100506134" HGNC_ID="HGNC:41115" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165933857" stop="165948321" display_start="165933857" display_stop="165948321" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="CSRNP3" FullName="cysteine and serine rich nuclear protein 3" GeneID="80034" HGNC_ID="HGNC:30729" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165469698" stop="165689407" display_start="165469698" display_stop="165689407" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166326156" stop="166545916" display_start="166326156" display_stop="166545916" Strand="+" />
          </Location>
          <OMIM>620405</OMIM>
        </Gene>
        <Gene Symbol="GALNT3" FullName="polypeptide N-acetylgalactosaminyltransferase 3" GeneID="2591" HGNC_ID="HGNC:4125" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165747588" stop="165794692" display_start="165747588" display_stop="165794692" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166604312" stop="166650802" display_start="166604312" display_stop="166650802" Strand="-" />
          </Location>
          <OMIM>601756</OMIM>
        </Gene>
        <Gene Symbol="LOC100506124" FullName="uncharacterized LOC100506124" GeneID="100506124" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165857475" stop="165871941" display_start="165857475" display_stop="165871941" Strand="-" />
          </Location>
        </Gene>
        <Gene Symbol="LOC102724058" FullName="uncharacterized LOC102724058" GeneID="102724058" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165957418" stop="166036400" display_start="165957418" display_stop="166036400" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC120977013" FullName="Sharpr-MPRA regulatory region 13511" GeneID="120977013" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165293739" stop="165294033" display_start="165293739" display_stop="165294033" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC126806396" FullName="BRD4-independent group 4 enhancer GRCh37_chr2:166317128-166318327" GeneID="126806396" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165460618" stop="165461817" display_start="165460618" display_stop="165461817" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129388938" FullName="MPRA-validated peak3912 silencer" GeneID="129388938" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165574005" stop="165574205" display_start="165574005" display_stop="165574205" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129935043" FullName="ATAC-STARR-seq lymphoblastoid silent region 12066" GeneID="129935043" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165193304" stop="165193353" display_start="165193304" display_stop="165193353" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129935044" FullName="ATAC-STARR-seq lymphoblastoid active region 16726" GeneID="129935044" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165595066" stop="165595115" display_start="165595066" display_stop="165595115" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129935045" FullName="ATAC-STARR-seq lymphoblastoid active region 16727" GeneID="129935045" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165595186" stop="165595235" display_start="165595186" display_stop="165595235" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129935046" FullName="ATAC-STARR-seq lymphoblastoid active region 16728" GeneID="129935046" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165874554" stop="165874753" display_start="165874554" display_stop="165874753" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC129935047" FullName="ATAC-STARR-seq lymphoblastoid active region 16729" GeneID="129935047" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165898024" stop="165898113" display_start="165898024" display_stop="165898113" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SCN1A" FullName="sodium voltage-gated channel alpha subunit 1" GeneID="6323" HGNC_ID="HGNC:10585" Source="submitted" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165984641" stop="166149161" display_start="165984641" display_stop="166149161" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166845669" stop="167005641" display_start="166845669" display_stop="167005641" Strand="-" />
          </Location>
          <OMIM>182389</OMIM>
          <Haploinsufficiency last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-07-06" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN1A">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SCN1A-AS1" FullName="SCN1A and SCN9A antisense RNA 1" GeneID="101929680" HGNC_ID="HGNC:54069" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="166081531" stop="166301784" display_start="166081531" display_stop="166301784" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="SCN2A" FullName="sodium voltage-gated channel alpha subunit 2" GeneID="6326" HGNC_ID="HGNC:10588" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165239414" stop="165392304" display_start="165239414" display_stop="165392304" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="166095911" stop="166248819" display_start="166095911" display_stop="166248819" Strand="+" />
          </Location>
          <OMIM>182390</OMIM>
          <Haploinsufficiency last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN2A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-04-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SCN2A">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="SCN3A" FullName="sodium voltage-gated channel alpha subunit 3" GeneID="6328" HGNC_ID="HGNC:10590" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>2q24.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="165087526" stop="165204050" display_start="165087526" display_stop="165204050" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="165944029" stop="166060576" display_start="165944029" display_stop="166060576" Strand="-" />
          </Location>
          <OMIM>182391</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000002.12:g.(?_165090130)_(166228992_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2q24.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" innerStart="165090130" innerStop="166228992" display_start="165090130" display_stop="166228992" variantLength="1138863" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" innerStart="165946640" innerStop="167085502" display_start="165946640" display_stop="167085502" variantLength="1138863" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.(?_165090130)_(166228992_?)del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.(?_165090130)_(166228992_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.(?_165946640)_(167085502_?)del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.(?_165946640)_(167085502_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000002.12:g.(?_165090130)_(166228992_?)del AND Early infantile epileptic encephalopathy with suppression bursts" Accession="RCV000636624" Version="2">
        <ClassifiedConditionList TraitSetID="21987">
          <ClassifiedCondition DB="MedGen" ID="C0393706">Early infantile epileptic encephalopathy with suppression bursts</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-12-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NC_000002.12:g.(?_165090130)_(166228992_?)del AND multiple conditions" Accession="RCV001387895" Version="4">
        <ClassifiedConditionList TraitSetID="32370">
          <ClassifiedCondition DB="MedGen" ID="C2751778">Generalized epilepsy with febrile seizures plus, type 7</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2752089">Neuropathy, hereditary sensory and autonomic, type 2A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-17" NumberOfSubmissions="2" NumberOfSubmitters="1" DateCreated="2018-05-28" MostRecentSubmission="2024-06-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17470132</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17561957</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18479393</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19400878</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21719429</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25439579</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25524840</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25995458</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="21987" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32998" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Developmental and epileptic encephalopathy</ElementValue>
                <XRef ID="MONDO:0100062" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Early infantile epileptic encephalopathy</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ohtahara syndrome</ElementValue>
                <XRef ID="1934" DB="Orphanet" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Early infantile epileptic encephalopathy with suppression bursts</ElementValue>
                <XRef ID="230429005" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">EIEE</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9255" />
                <XRef ID="9255" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="1934" DB="Orphanet" />
              <XRef ID="C0393706" DB="MedGen" />
              <XRef ID="MONDO:0100062" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS308350" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32370" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3458" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">ACROOSTEOLYSIS, GIACCAI TYPE</ElementValue>
                <XRef Type="MIM" ID="201300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ACROOSTEOLYSIS, NEUROGENIC</ElementValue>
                <XRef Type="MIM" ID="201300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Neuropathy, hereditary sensory and autonomic, type 2A</ElementValue>
                <XRef ID="MONDO:0024309" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HSAN IIA</ElementValue>
                <XRef Type="MIM" ID="201300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEUROPATHY, HEREDITARY SENSORY RADICULAR, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="201300" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NEUROPATHY, HEREDITARY SENSORY, TYPE IIA</ElementValue>
                <XRef Type="MIM" ID="201300" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605232.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605232.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605232.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605232.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605232.0008" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605232.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605232.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605232.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="605232.0004" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary sensory and autonomic neuropathy type IIA</ElementValue>
                <XRef ID="Hereditary+sensory+and+autonomic+neuropathy+type+IIA/8533" DB="Genetic Alliance" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HSAN2A</ElementValue>
                <XRef Type="MIM" ID="201300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HSN IIA</ElementValue>
                <XRef Type="MIM" ID="201300" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HSN2A</ElementValue>
                <XRef Type="MIM" ID="201300" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary sensory and autonomic neuropathy type II (HSAN2) is characterized by progressively reduced sensation to pain, temperature, and touch. Onset can be at birth and is often before puberty. The sensory deficit is predominantly distal with the lower limbs more severely affected than the upper limbs. Over time sensory function becomes severely reduced. Unnoticed injuries and neuropathic skin promote ulcerations and infections that result in spontaneous amputation of digits or the need for surgical amputation. Osteomyelitis is common. Painless fractures can complicate the disease. Autonomic disturbances are variable and can include hyperhidrosis, tonic pupils, and urinary incontinence in those with more advanced disease.</Attribute>
                <XRef ID="NBK49247" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">WNK1-Related HSAN2 (HSAN2A)</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15129" />
                <XRef ID="15129" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21089229</ID>
                <ID Source="BookShelf">NBK49247</ID>
              </Citation>
              <XRef ID="970" DB="Orphanet" />
              <XRef ID="C2752089" DB="MedGen" />
              <XRef ID="MONDO:0024309" DB="MONDO" />
              <XRef Type="MIM" ID="201300" DB="OMIM" />
            </Trait>
            <Trait ID="9400" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GEFS+, TYPE 7</ElementValue>
                <XRef Type="MIM" ID="613863" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Generalized epilepsy with febrile seizures plus, type 7</ElementValue>
                <XRef ID="Generalized+epilepsy+with+febrile+seizures+plus%2C+type+7/8461" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013470" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GEFS+7</ElementValue>
                <XRef Type="MIM" ID="613863" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">GEFSP7</ElementValue>
                <XRef Type="MIM" ID="613863" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18665" />
                <XRef ID="18665" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="36387" DB="Orphanet" />
              <XRef ID="C2751778" DB="MedGen" />
              <XRef ID="MONDO:0013470" DB="MONDO" />
              <XRef Type="MIM" ID="613863" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1467522" SubmissionDate="2018-04-02" DateLastUpdated="2018-05-28" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="3228997|MedGen:C0393706" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000758063" DateUpdated="2018-05-28" DateCreated="2018-05-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-12-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18479393</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21719429</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17561957</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25524840</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19400878</ID>
          </Citation>
          <Comment>A gross deletion of the genomic region encompassing the full coding sequence of the SCN1A gene has been identified. The boundaries of this event are unknown as the deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. Whole-gene deletions of SCN1A with and without deletion of additional surrounding genes have been reported in individuals affected with Dravet syndrome and myoclonic epilepsy in infancy (PMID: 19400878, 18479393, 25524840, 17561957, 21719429). Loss-of-function variants in SCN1A are known to be pathogenic (PMID: 17347258, 18930999). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_165946640)_(167085502_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0393706" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3114296" SubmissionDate="2024-06-04" DateLastUpdated="2024-06-09" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="NM_002977.3_2_Deletion (exons 22-27)|MedGen:C2752089;C2751777" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001588635" DateUpdated="2024-06-09" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">17470132</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25439579</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25995458</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 22-27 of the SCN9A gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. For these reasons, this variant has been classified as Pathogenic. This variant disrupts the C-terminus of the SCN9A protein. Other variant(s) that disrupt this region (p.Arg1488*, p.Lys1659*, p.Arg1599*, p.Leu1831*) have been observed in individuals with SCN9A-related conditions (PMID: 17470132, 25439579, 25995458). This suggests that this may be a clinically significant region of the protein. This variant has not been reported in the literature in individuals affected with SCN9A-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SCN9A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.(?_165946640)_(167085502_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2752089" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2751777" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14505679</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3114296" TraitType="Disease" MappingType="XRef" MappingValue="C2751777" MappingRef="MedGen">
        <MedGen CUI="C2751778" Name="Generalized epilepsy with febrile seizures plus, type 7" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3114296" TraitType="Disease" MappingType="XRef" MappingValue="C2752089" MappingRef="MedGen">
        <MedGen CUI="C2752089" Name="Neuropathy, hereditary sensory and autonomic, type 2A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1467522" TraitType="Disease" MappingType="XRef" MappingValue="C0393706" MappingRef="MedGen">
        <MedGen CUI="C0393706" Name="Early infantile epileptic encephalopathy with suppression bursts" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

